MEI Pharma Inc (MEIP)
2.78
-0.03
(-1.07%)
USD |
NASDAQ |
Nov 22, 16:00
2.79
+0.01
(+0.36%)
After-Hours: 20:00
MEI Pharma Revenue (Annual): 65.30M for June 30, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
June 30, 2024 | 65.30M |
June 30, 2023 | 48.82M |
June 30, 2022 | 40.70M |
June 30, 2021 | 34.80M |
June 30, 2020 | 27.76M |
June 30, 2019 | 4.915M |
June 30, 2018 | 1.622M |
June 30, 2017 | 23.25M |
June 30, 2016 | |
June 30, 2015 | |
June 30, 2014 | |
June 30, 2013 |
Date | Value |
---|---|
June 30, 2012 | |
June 30, 2011 | |
June 30, 2010 | |
June 30, 2009 | 0.228M |
June 30, 2008 | 0.674M |
June 30, 2007 | 0.645M |
June 30, 2006 | |
June 30, 2005 | |
June 30, 2004 | |
June 30, 2003 | 0.145M |
June 30, 2002 | 0.007M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
27.76M
Minimum
2020
65.30M
Maximum
2024
43.47M
Average
40.70M
Median
2022
Revenue (Annual) Benchmarks
Avid Bioservices Inc | 139.91M |
Evoke Pharma Inc | 5.181M |
Revance Therapeutics Inc | 234.04M |
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 4.490M |